<DOC>
	<DOCNO>NCT00467493</DOCNO>
	<brief_summary>Aromatase inhibitor approve use postmenopausal woman treat prevent breast cancer . They act block action enzyme , aromatase , necessary production estradiol . This class drug , aromatase inhibitor , effective reduce estradiol level postmenopausal woman treat estrogen receptor positive breast cancer . This study examine effect specific inhibitor , anastrozole , endometrial thickness premenopausal woman . The endometrium sensitive estradiol also local aromatase , inhibit , may result reduce endometrial thickness . The main hypothesis anastrozole administer time menstrual cycle reduce endometrial thickness compare placebo .</brief_summary>
	<brief_title>Partial Double-Blind , Placebo-Controlled Study Assess Effect Anastrozole Endometrium Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Menstruation Disturbances</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Between age 25 45 premenopausal ; Nonlactating pregnant able follow schedule procedure able freely provide informed consent clinically acceptable physical examination safety laboratory study current use form systemic contraceptive selfreported irregular menstrual cycle intercurrent illness ( e ) detect screen physical unwilling unable use barrier method contraception evidence endometrial polyp myomata TVU/SIS would interfere endometrial thickness measurement detection ovarian cyst ( ) adnexal examination screen TVU/SIS measure great 5 cm history , current cancer , form exclusive basal cell carcinoma BMI &gt; = 35 history alcohol drug abuse past 5 year unwilling unable undergo study procedure within necessary time frame history current liver abnormality define ALT AST &gt; 2X ULN treat untreated diabetes define fast blood sugar &gt; = 126 mg/dL untreated hypertension impair renal function estimate creatinine clearance &lt; 80mL/min estradiol level &lt; 20 pg/ml FSH level &gt; 40 mIU/mL history adverse reaction aromatase inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>